Prot# 440E-ONC-0047-140: Phz I Dose-Escalation Study to Eval. Max Tolerated Dose, Safety Profile & Bioavailability of Semi-Solid Matrix (SSM) Capsule Formulation of Orally Admin'd Irinotecan Hydrochloride (CPT-11) Given Alone or in Sequence w/ Orally Admi

Project: Research project

StatusFinished
Effective start/end date6/12/019/6/07

Funding

  • Pharmacia & Upjohn, Inc. (440E-ONC-0047-140)